Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis C

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 19 articles:
HTML format
Text format



Single Articles


    June 2017
  1. BOURLIERE M, Gordon SC, Flamm SL, Cooper CL, et al
    Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.
    N Engl J Med. 2017;376:2134-2146.
    PubMed     Text format     Abstract available


    April 2017
  2. GOLDBERG DS, Abt PL, Blumberg EA, Van Deerlin VM, et al
    Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients.
    N Engl J Med. 2017 Apr 30. doi: 10.1056/NEJMc1705221.
    PubMed     Text format    


    November 2016
  3. LEVITSKY J, Verna EC, O'Leary JG, Bzowej NH, et al
    Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients.
    N Engl J Med. 2016;375:2106-2108.
    PubMed     Text format    


    October 2016
  4. MACIOCIA N, O'Brien A, Ardeshna K
    Remission of Follicular Lymphoma after Treatment for Hepatitis C Virus Infection.
    N Engl J Med. 2016;375:1699-1701.
    PubMed     Text format    


    July 2016
  5. PETERS PJ, Pontones P, Hoover KW, Patel MR, et al
    HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015.
    N Engl J Med. 2016;375:229-39.
    PubMed     Text format     Abstract available


    April 2016
  6. ASSY N, Barhoum M
    Sofosbuvir and Velpatasvir for Patients with HCV Infection.
    N Engl J Med. 2016;374:1687-9.
    PubMed     Text format     Abstract available



  7. Sofosbuvir and Velpatasvir for Patients with HCV Infection.
    N Engl J Med. 2016;374:1687-9.
    PubMed     Text format     Abstract available


  8. FELD JJ, Zeuzem S
    Sofosbuvir and Velpatasvir for Patients with HCV Infection.
    N Engl J Med. 2016;374:1688-9.
    PubMed     Text format    


  9. CURRY MP, Charlton M
    Sofosbuvir and Velpatasvir for Patients with HCV Infection.
    N Engl J Med. 2016;374:1688.
    PubMed     Text format    


    November 2015
  10. WARD JW, Mermin JH
    Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  11. FOSTER GR, Afdhal N, Roberts SK, Brau N, et al
    Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  12. FELD JJ, Jacobson IM, Hezode C, Asselah T, et al
    Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  13. CURRY MP, O'Leary JG, Bzowej N, Muir AJ, et al
    Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  14. FONTAINE H, Lazarus A, Pol S, Pecriaux C, et al
    Bradyarrhythmias Associated with Sofosbuvir Treatment.
    N Engl J Med. 2015;373:1886-8.
    PubMed     Text format    


    September 2015
  15. LIAO JM, Fischer MA
    Early Patterns of Sofosbuvir Utilization by State Medicaid Programs.
    N Engl J Med. 2015;373:1279-81.
    PubMed     Text format    


    August 2015
  16. WILKIN T
    Primary Care for Men Who Have Sex with Men.
    N Engl J Med. 2015;373:854-862.
    PubMed     Text format     Abstract available


    July 2015
  17. REESE PP, Abt PL, Blumberg EA, Goldberg DS, et al
    Transplanting Hepatitis C-Positive Kidneys.
    N Engl J Med. 2015;373:303-5.
    PubMed     Text format    


  18. NAGGIE S, Cooper C, Saag M, Workowski K, et al
    Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  19. WYLES DL, Ruane PJ, Sulkowski MS, Dieterich D, et al
    Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: